The role of cytoskeletal proteins in cardiomyopathies

JA Towbin - Current opinion in cell biology, 1998 - Elsevier
JA Towbin
Current opinion in cell biology, 1998Elsevier
Cardiomyopathies are serious heart muscle disorders in children and adults, which result in
morbidity and premature death. These disorders include hypertrophic cardiomyopathy,
dilated cardiomyopathy and restrictive cardiomyopathy. Recently, mutations in seven genes,
all encoding sarcomeric proteins, have been identified as causes of familial hypertrophic
cardiomyopathy. The gene include those encoding the β-myosin heavy chain, α-
tropomyosin, cardiac troponin T, myosin binding protein-C, myosin essential light chain …
Cardiomyopathies are serious heart muscle disorders in children and adults, which result in morbidity and premature death. These disorders include hypertrophic cardiomyopathy, dilated cardiomyopathy and restrictive cardiomyopathy. Recently, mutations in seven genes, all encoding sarcomeric proteins, have been identified as causes of familial hypertrophic cardiomyopathy. The gene include those encoding the β-myosin heavy chain, α-tropomyosin, cardiac troponin T, myosin binding protein-C, myosin essential light chain, myosin regulatory light chain, and troponin I. Advances in the understanding of dilated cardiomyopathy have been made recently as well and it appears as if cytoskeletal proteins play a central role. Dystrophin has been identified as the gene responsible for X-linked dilated cardiomyopathy and this protein, which is also responsible for Duchenne and Becker muscular dystrophy, plays an important role in myocyte and cardiomyocyte function. Mutations in order cytoskeletal proteins such as metavinculin, α-dystroglycan, α- and γ-sarcoglycan, and muscle LIM protein have also been found to result in dilated cardiomyopathy, suggesting that cytoskeletal proteins play a central role in cardiac function.
Elsevier